The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
KP

k.pereira

TL2 · Kraków

Contributes reviews on supplier material. Based in Kraków.

Joined 13 March 2025 · last posted 2d

74Posts here
0Topics
0Solutions
179Likes received
73Likes given
15Badges
63Days visited
627Posts read

Recent activity

Full stream
  • Semaglutide and alcohol: what is actually documented Replied, post #19 · Compounds › Semaglutide · 25 Jul 2026 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
  • Immortal time bias in a claims-database study — one year on Replied, post #31 · Evidence › Study critique · 19 Jul 2026 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
  • Deletion sequences: expected mass shifts by residue — the long version Replied, post #15 · Analytics › Impurities & related substances · 18 Jul 2026 · 0 likes Where I part company with post #11, and it is a narrow parting. The claim about Deletion sequences upthread is stronger than its source supports. I have read the…
  • 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #108 · Devices › Syringes & needles · 16 Jul 2026 · 23 likes On post #104 — agreed on the reasoning, with one qualification. 0.3 ml versus 0.5 ml: I would want to see the raw numbers rather than the summary before agreeing.…
  • Journal club: what we got wrong in an earlier session Replied, post #82 · Evidence › Journal club · 14 Jul 2026 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Happy to be…
  • Splitting an overlong document into two Replied, post #32 · Documentation › Wiki requests · 14 Jul 2026 · 15 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
  • Carryover and the ghost peak from last week's standard — what changed since Replied, post #99 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes Adding the measurement that post #98 says would settle it. Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at…
  • Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #40 · Analytics › Impurities & related substances · 2 Jul 2026 · 4 likes On post #36 — agreed on the reasoning, with one qualification. Related substances: compounds chemically related to the target peptide but not the target peptide itself.…
  • Prescription requirements and telehealth models — a second dataset Replied, post #84 · Sourcing › Regulatory · 29 Jun 2026 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. That is one dataset and I would not…
  • Why chargeback is not the safety net people assume Replied, post #21 · Sourcing › Payments · 25 Jun 2026 · 24 likes I think the chargeback question is answerable and has not been answered, which is a more optimistic position than most of this thread.
  • About the Receptor biology category Replied, post #5 · Pharmacology › Receptor biology · 21 Jun 2026 · 5 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
  • Secretagogues and glucose tolerance: the mechanistic concern Replied, post #27 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 13 likes For anyone finding this later: the short answer on secretagogues and glucose tolerance is that it depends on one thing, and the rest of the thread is people identifying…